Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pivotal Phase II, Multicenter, Single-arm, Two-cohort Trial Evaluating the Efficacy and Safety of GDC-0449 in Patients With Advanced Basal Cell Carcinoma

NCT00833417 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT00833417
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00833417 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pivotal Phase II, Multicenter, Single-arm, Two-cohort Trial Evaluating the Efficacy and Safety of GDC-0449 in Patients With Advanced Basal Cell Carcinoma
Lead sponsor
Genentech, Inc.
Phase
Phase 2
Overall status
Completed
Start date
February 10, 2009
Completion date
April 9, 2014
Enrollment
104 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

basal cell carcinoma